首页 > 最新文献

Colorectal Disease最新文献

英文 中文
Patient characteristics, antibiotic use, and in-hospital outcomes in patients with ischaemic colitis: A nationwide retrospective cohort study. 缺血性结肠炎患者的患者特征、抗生素使用和住院结果:一项全国性回顾性队列研究
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70385
Yasuhiro Kano, Yuya Kimura, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga

Aim: To describe patient characteristics, management and in-hospital outcomes of ischaemic colitis, and to compare the rates of surgery and in-hospital death between patients who did and did not receive antibiotics.

Method: We retrospectively identified hospital admissions for ischaemic colitis between April 2016 and March 2023 from the Diagnosis Procedure Combination inpatient database in Japan. We described the overall patient characteristics, management practices and outcomes, which were stratified by antibiotic use. The primary outcome was a composite of receipt of surgery and in-hospital mortality. We examined the association between antibiotic use within the first 2 days of admission and the primary outcome occurring on or after day 3 of hospitalization using multivariable logistic regression analyses.

Results: Among 111,750 eligible cases, 36.2% received antibiotics within the first 2 days of admission. Of them, 0.9% underwent surgery and 1.3% died during hospitalization. The primary outcome occurred in 2.1% of cases in the overall cohort (≤2 days: 0.6%; ≥3 days: 1.5%) and in 1.0% of cases who did not receive (≤2 days: 0.2%; ≥3 days: 0.8%) and 4.2% of cases who received antibiotics (≤2 days: 1.5%; ≥3 days: 2.7%). After covariate adjustment, antibiotic use was associated with higher odds of the primary composite outcome (adjusted odds ratio 1.98, 95% confidence interval: 1.77-2.21).

Conclusion: The surgical rate and in-hospital mortality in ischaemic colitis were lower than previously reported. Antibiotic use was associated with higher odds of surgery and in-hospital mortality; however, this finding should be interpreted cautiously, given potential unmeasured confounding.

目的:描述缺血性结肠炎的患者特征、治疗和住院结果,并比较接受和未接受抗生素治疗的患者的手术率和住院死亡率。方法:我们回顾性地从日本诊断程序组合住院患者数据库中确定2016年4月至2023年3月期间的缺血性结肠炎住院患者。我们描述了患者的总体特征、管理实践和结果,并根据抗生素的使用进行了分层。主要结局是接受手术和住院死亡率的综合结果。我们使用多变量logistic回归分析检查了入院前2天内抗生素使用与住院第3天或之后发生的主要结局之间的关系。结果:在111,750例符合条件的病例中,36.2%的患者在入院前2天内使用了抗生素。其中0.9%接受手术治疗,1.3%在住院期间死亡。在整个队列中,2.1%的病例(≤2天:0.6%;≥3天:1.5%)、1.0%的未接受抗生素治疗的病例(≤2天:0.2%;≥3天:0.8%)和4.2%接受抗生素治疗的病例(≤2天:1.5%;≥3天:2.7%)出现了主要结局。协变量调整后,抗生素的使用与主要综合结局的较高几率相关(调整后的优势比为1.98,95%可信区间为1.77-2.21)。结论:缺血性结肠炎的手术率和住院死亡率低于文献报道。抗生素的使用与更高的手术几率和住院死亡率相关;然而,考虑到潜在的未测量的混杂因素,这一发现应谨慎解释。
{"title":"Patient characteristics, antibiotic use, and in-hospital outcomes in patients with ischaemic colitis: A nationwide retrospective cohort study.","authors":"Yasuhiro Kano, Yuya Kimura, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga","doi":"10.1111/codi.70385","DOIUrl":"10.1111/codi.70385","url":null,"abstract":"<p><strong>Aim: </strong>To describe patient characteristics, management and in-hospital outcomes of ischaemic colitis, and to compare the rates of surgery and in-hospital death between patients who did and did not receive antibiotics.</p><p><strong>Method: </strong>We retrospectively identified hospital admissions for ischaemic colitis between April 2016 and March 2023 from the Diagnosis Procedure Combination inpatient database in Japan. We described the overall patient characteristics, management practices and outcomes, which were stratified by antibiotic use. The primary outcome was a composite of receipt of surgery and in-hospital mortality. We examined the association between antibiotic use within the first 2 days of admission and the primary outcome occurring on or after day 3 of hospitalization using multivariable logistic regression analyses.</p><p><strong>Results: </strong>Among 111,750 eligible cases, 36.2% received antibiotics within the first 2 days of admission. Of them, 0.9% underwent surgery and 1.3% died during hospitalization. The primary outcome occurred in 2.1% of cases in the overall cohort (≤2 days: 0.6%; ≥3 days: 1.5%) and in 1.0% of cases who did not receive (≤2 days: 0.2%; ≥3 days: 0.8%) and 4.2% of cases who received antibiotics (≤2 days: 1.5%; ≥3 days: 2.7%). After covariate adjustment, antibiotic use was associated with higher odds of the primary composite outcome (adjusted odds ratio 1.98, 95% confidence interval: 1.77-2.21).</p><p><strong>Conclusion: </strong>The surgical rate and in-hospital mortality in ischaemic colitis were lower than previously reported. Antibiotic use was associated with higher odds of surgery and in-hospital mortality; however, this finding should be interpreted cautiously, given potential unmeasured confounding.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70385"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Five-year recurrence and postoperative complications after laparoscopic complete Mesocolic excision: A population-based, multicentred study. 腹腔镜完整肠系膜切除术后5年复发和术后并发症:一项基于人群的多中心研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70380
Tora Haug, Jan Brink Valentin, Mai-Britt Worm Ørntoft, Lene Hjerrild Iversen, Søren Paaske Johnsen, Robin Kennedy, Danilo Miskovic, Anders Husted Madsen

Background: The oncological benefits of Laparoscopic Complete Mesocolic Excision (LCME) over conventional surgery are often challenged by single-centre designs, small cohorts or short and incomplete follow-up. This study aimed to examine the difference in recurrence risk 5 years after surgery and 30-day postoperative complications before and after a population-based, multicentre LCME implementation.

Method: LCME was implemented in the Central Denmark Region, Denmark following a training programme in 2017 for all colon cancer surgeons. Colon cancer patients from before (2015-2016, PRE-group) and after the implementation (2018-2019, POST-group) were identified through the Danish Colorectal Cancer Group Database. Recurrence 5 years after surgery was ascertained through national registers using a validated algorithm. The Aalen-Johansen estimator for competing risk was used to calculate cumulative incidence of recurrence.

Results: A total of 1919 patients (PRE, n = 1024; POST, n = 895) underwent curative-intended surgery in the study period. The 5-year cumulative incidence of recurrence was 16.1% (95% CI: 13.8, 18.4) in the PRE group and 12.5% (95% CI: 10.2, 14.9) in the POST group, with a significant absolute risk difference of 3.6% (95% CI: 0.3, 6.9). Furthermore, a significantly lower hazard rate of recurrence was observed in stage II patients after the LCME implementation, with a hazard rate ratio of 0.42 (95% Cl: 0.24, 0.72). Risk of severe postoperative complications was also significantly lower in the POST, compared to the PRE group.

Conclusion: LCME implementation was associated with a significantly lower risk of recurrence and lower rate of severe postoperative complications. This study indicates that multicentre LCME implementation may improve clinical outcomes without compromising patient safety.

背景:腹腔镜完整肠系膜切除术(LCME)相对于传统手术的肿瘤学益处经常受到单中心设计、小队列或短且不完整随访的挑战。本研究旨在研究以人群为基础的多中心LCME实施前后术后5年复发风险和术后30天并发症的差异。方法:LCME在2017年对所有结肠癌外科医生进行培训后在丹麦中部地区实施。通过丹麦结直肠癌组数据库确定实施前(2015-2016,pre -2016组)和实施后(2018-2019,post组)的结肠癌患者。术后5年复发率通过国家登记系统确定。竞争风险的aallen - johansen估计用于计算累积复发率。结果:在研究期间,共有1919例患者(PRE, n = 1024; POST, n = 895)接受了治愈性手术。PRE组5年累积复发率为16.1% (95% CI: 13.8, 18.4), POST组5年累积复发率为12.5% (95% CI: 10.2, 14.9),绝对风险差异为3.6% (95% CI: 0.3, 6.9)。此外,LCME实施后II期患者的危险复发率显著降低,危险率比为0.42 (95% Cl: 0.24, 0.72)。与PRE组相比,POST组发生严重术后并发症的风险也显著降低。结论:LCME的实施显著降低了复发风险和术后严重并发症的发生率。本研究表明,多中心LCME的实施可以在不影响患者安全的情况下改善临床结果。
{"title":"Five-year recurrence and postoperative complications after laparoscopic complete Mesocolic excision: A population-based, multicentred study.","authors":"Tora Haug, Jan Brink Valentin, Mai-Britt Worm Ørntoft, Lene Hjerrild Iversen, Søren Paaske Johnsen, Robin Kennedy, Danilo Miskovic, Anders Husted Madsen","doi":"10.1111/codi.70380","DOIUrl":"https://doi.org/10.1111/codi.70380","url":null,"abstract":"<p><strong>Background: </strong>The oncological benefits of Laparoscopic Complete Mesocolic Excision (LCME) over conventional surgery are often challenged by single-centre designs, small cohorts or short and incomplete follow-up. This study aimed to examine the difference in recurrence risk 5 years after surgery and 30-day postoperative complications before and after a population-based, multicentre LCME implementation.</p><p><strong>Method: </strong>LCME was implemented in the Central Denmark Region, Denmark following a training programme in 2017 for all colon cancer surgeons. Colon cancer patients from before (2015-2016, PRE-group) and after the implementation (2018-2019, POST-group) were identified through the Danish Colorectal Cancer Group Database. Recurrence 5 years after surgery was ascertained through national registers using a validated algorithm. The Aalen-Johansen estimator for competing risk was used to calculate cumulative incidence of recurrence.</p><p><strong>Results: </strong>A total of 1919 patients (PRE, n = 1024; POST, n = 895) underwent curative-intended surgery in the study period. The 5-year cumulative incidence of recurrence was 16.1% (95% CI: 13.8, 18.4) in the PRE group and 12.5% (95% CI: 10.2, 14.9) in the POST group, with a significant absolute risk difference of 3.6% (95% CI: 0.3, 6.9). Furthermore, a significantly lower hazard rate of recurrence was observed in stage II patients after the LCME implementation, with a hazard rate ratio of 0.42 (95% Cl: 0.24, 0.72). Risk of severe postoperative complications was also significantly lower in the POST, compared to the PRE group.</p><p><strong>Conclusion: </strong>LCME implementation was associated with a significantly lower risk of recurrence and lower rate of severe postoperative complications. This study indicates that multicentre LCME implementation may improve clinical outcomes without compromising patient safety.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70380"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facilitating endorobotic submucosal dissection (ERSD) in transanal single-port surgery: A comparative analysis of two ports-A video vignette. 在经肛门单孔手术中促进内生机器人粘膜下剥离(ERSD):两个孔的比较分析-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70400
Ece Erenler, Metincan Erkaya, Mustafa Oruc, Salih Nafiz Karahan, Emre Gorgun
{"title":"Facilitating endorobotic submucosal dissection (ERSD) in transanal single-port surgery: A comparative analysis of two ports-A video vignette.","authors":"Ece Erenler, Metincan Erkaya, Mustafa Oruc, Salih Nafiz Karahan, Emre Gorgun","doi":"10.1111/codi.70400","DOIUrl":"https://doi.org/10.1111/codi.70400","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70400"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological considerations regarding long-term performance and interpretation of faecal immunochemical testing. 关于粪便免疫化学检测的长期性能和解释的方法学考虑。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70386
Ting Chen
{"title":"Methodological considerations regarding long-term performance and interpretation of faecal immunochemical testing.","authors":"Ting Chen","doi":"10.1111/codi.70386","DOIUrl":"10.1111/codi.70386","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70386"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological profile of surgical treatment for colorectal cancer: Retrospective analysis of trends and regional disparities in Brazil, 2014-2024. 结直肠癌手术治疗的流行病学概况:2014-2024年巴西趋势和地区差异的回顾性分析
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70387
Felipe Mendes Delpino, Francisco Tustumi, Marina Martins Siqueira, Gabriely Rangel Pereira, Marcelo Passos Teivelis, Lucas Hernandes Correa, Nelson Wolosker

Background: Colorectal cancer (CRC) represents a major challenge for public health in Brazil due to its high incidence and mortality. This study examines temporal trends, regional disparities and outcomes of CRC surgeries performed in Brazil between 2014 and 2024.

Methods: We conducted a retrospective observational analysis using data from the Hospital Information System of the Unified Health System (SIH-SUS). We included all patients who underwent CRC surgery financed by the SUS during the period. We analysed patient demographics, surgery rates per 100,000 inhabitants (excluding the population covered by voluntary private health insurance), in-hospital mortality and length of stay in the five geographic regions of Brazil.

Results: In total, we identified 313,531 CRC surgeries. Most patients were between 60 and 69 years old (30.1%), with a similar distribution between genders (50.2% men). Surgery rates varied considerably across regions, from 51.4 per 100,000 inhabitants in the North to 319.9 in the South. In-hospital mortality ranged from 5.2% to 6.7%, with variation among geographic regions. The number of procedures increased by 74% during the period, except for a decline in 2020, possibly related to the COVID-19 pandemic.

Conclusion: Our findings reveal substantial regional heterogeneity in surgical provision and in-hospital outcomes for CRC within the Brazilian public health system, particularly affecting the North region. These descriptive patterns may inform health system monitoring and future policy-oriented research and decision making.

背景:结直肠癌(CRC)由于其高发病率和死亡率,是巴西公共卫生面临的主要挑战。本研究考察了2014年至2024年间巴西CRC手术的时间趋势、地区差异和结果。方法:我们使用统一卫生系统医院信息系统(SIH-SUS)的数据进行回顾性观察分析。我们纳入了在此期间接受由SUS资助的结直肠癌手术的所有患者。我们分析了巴西五个地理区域的患者人口统计数据、每10万居民的手术率(不包括自愿私人健康保险覆盖的人口)、住院死亡率和住院时间。结果:我们共发现313531例结直肠癌手术。大多数患者年龄在60 - 69岁之间(30.1%),性别分布相似(男性50.2%)。各地区的手术率差别很大,从北方的每10万居民51.4例到南方的每10万居民319.9例。住院死亡率从5.2%到6.7%不等,因地理区域而异。在此期间,手术数量增加了74%,但2020年有所下降,这可能与COVID-19大流行有关。结论:我们的研究结果揭示了巴西公共卫生系统中CRC手术提供和住院结果的重大区域异质性,特别是影响北部地区。这些描述性模式可为卫生系统监测和未来面向政策的研究和决策提供信息。
{"title":"Epidemiological profile of surgical treatment for colorectal cancer: Retrospective analysis of trends and regional disparities in Brazil, 2014-2024.","authors":"Felipe Mendes Delpino, Francisco Tustumi, Marina Martins Siqueira, Gabriely Rangel Pereira, Marcelo Passos Teivelis, Lucas Hernandes Correa, Nelson Wolosker","doi":"10.1111/codi.70387","DOIUrl":"https://doi.org/10.1111/codi.70387","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) represents a major challenge for public health in Brazil due to its high incidence and mortality. This study examines temporal trends, regional disparities and outcomes of CRC surgeries performed in Brazil between 2014 and 2024.</p><p><strong>Methods: </strong>We conducted a retrospective observational analysis using data from the Hospital Information System of the Unified Health System (SIH-SUS). We included all patients who underwent CRC surgery financed by the SUS during the period. We analysed patient demographics, surgery rates per 100,000 inhabitants (excluding the population covered by voluntary private health insurance), in-hospital mortality and length of stay in the five geographic regions of Brazil.</p><p><strong>Results: </strong>In total, we identified 313,531 CRC surgeries. Most patients were between 60 and 69 years old (30.1%), with a similar distribution between genders (50.2% men). Surgery rates varied considerably across regions, from 51.4 per 100,000 inhabitants in the North to 319.9 in the South. In-hospital mortality ranged from 5.2% to 6.7%, with variation among geographic regions. The number of procedures increased by 74% during the period, except for a decline in 2020, possibly related to the COVID-19 pandemic.</p><p><strong>Conclusion: </strong>Our findings reveal substantial regional heterogeneity in surgical provision and in-hospital outcomes for CRC within the Brazilian public health system, particularly affecting the North region. These descriptive patterns may inform health system monitoring and future policy-oriented research and decision making.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70387"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis. 前列腺癌放疗后直肠癌:倾向匹配分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70365
M Goldenshluger, M A Abbas, M Belkovsky, A Alipouriani, K Erozkan, G Alon, M A Valente, S R Steele, S D Holubar, D Liska, E Gorgun
<p><strong>Aim: </strong>Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized. This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.</p><p><strong>Methods: </strong>Retrospective cohort study using univariate and propensity-matched analyses. Data extracted from electronic medical records at a single tertiary institution [2001-2021]. Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a <3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.</p><p><strong>Results: </strong>Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (p < 0.001), and a higher American Society of Anaesthesiologists (ASA) score (p = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (p = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (p = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%-71%) and PRC (50.3%, 95% CI: 36%-64%) groups (p = 0.61).</p><p><strong>Limitations: </strong>Retrospective design and reliance on electronic medical records from a single institution.</p><p><strong>Conclusion: </strong>Patients with PPC developed SRC up to 10 years after radiation therapy. Patients with SRC were typically older with more comorbidities. Fewer patients with SRC underwent neoadjuvant therapy, and as a group, required more extensive surgeries with a lower rate of sphincter preservation compared to patients with PRC. Despite these differences, patients with SRC had similar pathological outcomes and overall survival compared to pat
目的:先前接受过原发性前列腺癌(PPC)放射治疗的患者患继发性直肠癌(SRC)的风险升高。然而,在这种情况下,SRC的临床表现、手术结果和肿瘤结果仍然缺乏特征。本研究旨在比较原发性直肠癌(PRC)患者和SRC患者在前列腺癌放疗后的临床和病理特征以及治疗结果。方法:回顾性队列研究,采用单变量分析和倾向匹配分析。数据摘自单一高等教育机构的电子病历[2001-2021]。有或没有前列腺癌放疗史的男性直肠癌(RC)患者行肿瘤切除术。结果:在1755例RC患者中,50例(2.9%)发生了SRC。50名患者中的43名被纳入分析。从放疗到SRC诊断的中位时间为8±4年(IQR)。SRC患者年龄较大,平均年龄为73.7±8.5岁,对照组为61.1±13岁(p局限性:回顾性设计和对单一机构电子病历的依赖)。结论:PPC患者在放疗后10年出现SRC。SRC患者通常年龄较大,合并症较多。与PRC患者相比,接受新辅助治疗的SRC患者较少,并且作为一个群体,与PRC患者相比,需要更广泛的手术,括约肌保留率更低。尽管存在这些差异,与PRC患者相比,SRC患者具有相似的病理结果和总生存期。
{"title":"Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis.","authors":"M Goldenshluger, M A Abbas, M Belkovsky, A Alipouriani, K Erozkan, G Alon, M A Valente, S R Steele, S D Holubar, D Liska, E Gorgun","doi":"10.1111/codi.70365","DOIUrl":"10.1111/codi.70365","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized. This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Retrospective cohort study using univariate and propensity-matched analyses. Data extracted from electronic medical records at a single tertiary institution [2001-2021]. Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a &lt;3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (p &lt; 0.001), and a higher American Society of Anaesthesiologists (ASA) score (p = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (p = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (p = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%-71%) and PRC (50.3%, 95% CI: 36%-64%) groups (p = 0.61).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Retrospective design and reliance on electronic medical records from a single institution.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Patients with PPC developed SRC up to 10 years after radiation therapy. Patients with SRC were typically older with more comorbidities. Fewer patients with SRC underwent neoadjuvant therapy, and as a group, required more extensive surgeries with a lower rate of sphincter preservation compared to patients with PRC. Despite these differences, patients with SRC had similar pathological outcomes and overall survival compared to pat","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70365"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12852529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assurance of rectal side arterial and venous perfusion with indocyanine green fluorescence angiography during anterior resection-A Video Vignette. 用吲哚菁绿荧光血管造影检查直肠侧动脉和静脉在前切除术中的灌注-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70394
Ronan A Cahill
{"title":"Assurance of rectal side arterial and venous perfusion with indocyanine green fluorescence angiography during anterior resection-A Video Vignette.","authors":"Ronan A Cahill","doi":"10.1111/codi.70394","DOIUrl":"10.1111/codi.70394","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70394"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146117889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of intraoperative ICG fluorescence angiography to reduce anastomotic leak in left-sided colorectal resections: A systematic review and meta-analysis of RCTs. 术中应用ICG荧光血管造影减少左侧结直肠切除术吻合口漏:随机对照试验的系统回顾和荟萃分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70378
Ahmed Boalot, JihDar Yau, Mahmudul Hasan, Xuanping Wang, Amira Younes, Madeline Hannah, Muneer Junejo

Aim: Anastomotic leak remains a serious complication after left-sided colorectal resection with substantial morbidity, mortality and healthcare costs. This systematic review and meta-analysis evaluated whether intraoperative indocyanine green (ICG) fluorescence angiography reduces anastomotic leak rates in patients undergoing left-sided colorectal resections.

Methods: A systematic search of major databases and trial registries was conducted for RCTs comparing ICG angiography with standard visual assessment in adults undergoing elective left-sided colorectal resection. The primary outcomes were overall and clinically significant (ISGRC Grade B/C) anastomotic leak. Risk ratios (RRs) were pooled using a random-effects model. Risk of bias was assessed with the Cochrane ROB2 tool.

Results: Ten trials involving 3,772 patients were included. ICG fluorescence angiography, compared to control, reduced overall anastomotic leak (RR 0.62, 95% CI 0.53-0.73; I2 = 0%; prediction interval 0.50-0.77) and clinically significant leak (RR 0.66, 95% CI 0.51-0.85; I2 = 0%). Assuming a 10% baseline leak rate, ICG prevents one leak per 27 patients treated. Subgroup analysis showed benefit even when ICG did not prompt surgical plan modification (RR 0.67, 95% CI 0.50-0.90). Between-study heterogeneity was negligible across all analyses. ICG use did not prolong operating time and has reduced postoperative complications (RR 0.88, 95% CI 0.73-1.05).

Conclusion: Intraoperative ICG fluorescence angiography significantly reduces anastomotic leak rates after left-sided colorectal resection, with consistent benefit across diverse surgical settings. The technology is practical and does not prolong operating time. ICG angiography should be considered a valuable adjunct in left-sided colorectal resections.

目的:吻合口漏是左侧结直肠切除术后的一个严重并发症,具有很高的发病率、死亡率和医疗费用。本系统综述和荟萃分析评估术中吲哚菁绿(ICG)荧光血管造影是否能降低左侧结肠直肠癌切除术患者的吻合口漏率。方法:对主要数据库和试验注册库进行系统检索,比较ICG血管造影和标准视觉评估在成人择期左侧结肠直肠切除术中的应用。主要结局是总体和临床显著(ISGRC分级B/C)吻合口漏。风险比(rr)采用随机效应模型汇总。采用Cochrane ROB2工具评估偏倚风险。结果:纳入10项试验,涉及3772例患者。与对照组相比,ICG荧光血管造影减少了吻合口总漏(RR 0.62, 95% CI 0.53-0.73; I2 = 0%;预测区间0.50-0.77)和临床显著漏(RR 0.66, 95% CI 0.51-0.85; I2 = 0%)。假设基线泄漏率为10%,ICG可防止每27名患者发生一次泄漏。亚组分析显示,即使ICG没有提示手术计划修改,也有益处(RR 0.67, 95% CI 0.50-0.90)。在所有分析中,研究间异质性可以忽略不计。使用ICG没有延长手术时间,减少了术后并发症(RR 0.88, 95% CI 0.73-1.05)。结论:术中ICG荧光血管造影可显著降低左侧结直肠切除术后吻合口漏率,在不同手术环境下均有一致的益处。该技术实用,不延长作业时间。ICG血管造影在左侧结肠直肠切除术中是一种有价值的辅助手段。
{"title":"Use of intraoperative ICG fluorescence angiography to reduce anastomotic leak in left-sided colorectal resections: A systematic review and meta-analysis of RCTs.","authors":"Ahmed Boalot, JihDar Yau, Mahmudul Hasan, Xuanping Wang, Amira Younes, Madeline Hannah, Muneer Junejo","doi":"10.1111/codi.70378","DOIUrl":"https://doi.org/10.1111/codi.70378","url":null,"abstract":"<p><strong>Aim: </strong>Anastomotic leak remains a serious complication after left-sided colorectal resection with substantial morbidity, mortality and healthcare costs. This systematic review and meta-analysis evaluated whether intraoperative indocyanine green (ICG) fluorescence angiography reduces anastomotic leak rates in patients undergoing left-sided colorectal resections.</p><p><strong>Methods: </strong>A systematic search of major databases and trial registries was conducted for RCTs comparing ICG angiography with standard visual assessment in adults undergoing elective left-sided colorectal resection. The primary outcomes were overall and clinically significant (ISGRC Grade B/C) anastomotic leak. Risk ratios (RRs) were pooled using a random-effects model. Risk of bias was assessed with the Cochrane ROB2 tool.</p><p><strong>Results: </strong>Ten trials involving 3,772 patients were included. ICG fluorescence angiography, compared to control, reduced overall anastomotic leak (RR 0.62, 95% CI 0.53-0.73; I<sup>2</sup> = 0%; prediction interval 0.50-0.77) and clinically significant leak (RR 0.66, 95% CI 0.51-0.85; I<sup>2</sup> = 0%). Assuming a 10% baseline leak rate, ICG prevents one leak per 27 patients treated. Subgroup analysis showed benefit even when ICG did not prompt surgical plan modification (RR 0.67, 95% CI 0.50-0.90). Between-study heterogeneity was negligible across all analyses. ICG use did not prolong operating time and has reduced postoperative complications (RR 0.88, 95% CI 0.73-1.05).</p><p><strong>Conclusion: </strong>Intraoperative ICG fluorescence angiography significantly reduces anastomotic leak rates after left-sided colorectal resection, with consistent benefit across diverse surgical settings. The technology is practical and does not prolong operating time. ICG angiography should be considered a valuable adjunct in left-sided colorectal resections.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70378"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TAMIS procedure for a recurrent rectal lesion at anastomotic site-A video vignette. 吻合口复发性直肠病变的TAMIS手术-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70389
Ejaz Ahmed Latif, Ali Toffaha, Ammar Aleter, Amjad Parvaiz, Mohamed Abu Nada, Mohamed Kurer
{"title":"TAMIS procedure for a recurrent rectal lesion at anastomotic site-A video vignette.","authors":"Ejaz Ahmed Latif, Ali Toffaha, Ammar Aleter, Amjad Parvaiz, Mohamed Abu Nada, Mohamed Kurer","doi":"10.1111/codi.70389","DOIUrl":"10.1111/codi.70389","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70389"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translating rectopexy practice variability into precision care innovative directions. 将直肠矫正术实践的可变性转化为精准护理的创新方向。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70391
Zejun Song, Yiqi Guo
{"title":"Translating rectopexy practice variability into precision care innovative directions.","authors":"Zejun Song, Yiqi Guo","doi":"10.1111/codi.70391","DOIUrl":"10.1111/codi.70391","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70391"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colorectal Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1